Jennifer A. Fox - 28 Feb 2023 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Role: Chief Financial Officer
Signature: Jennifer A. Fox, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol: NUVB
Transactions as of: 28 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 02 Mar 2023, 16:58:54 UTC
Previous filing: 22 Sep 2022
Next filing: 13 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NUVB	Class A Common Stock						4,481	28 Feb 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUVB	Stock Option (Right to Buy)	Award	$0	+600,000		$0.000000	600,000	28 Feb 2023	Class A Common Stock	600,000	$1.94	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 2,774 shares acquired on May 19, 2022 and 1 share acquired on November 18, 2022 under the Issuer's 2021 Employee Stock Purchase Plan.
F2	Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.